ascophyllum and Dyslipidemias

ascophyllum has been researched along with Dyslipidemias* in 1 studies

Trials

1 trial(s) available for ascophyllum and Dyslipidemias

Article	Year
Ascophyllum nodosum and Fucus vesiculosus on glycemic status and on endothelial damage markers in dysglicemic patients. Phytotherapy research : PTR, 2019, Volume: 33, Issue:3 The aim of this study was to evaluate a nutraceutical combination containing polyphenols extracted from Ascophyllum nodosum and Fucus vesiculosus and chromium picolinate on glyemic status; secondary outcomes were considered the changes on endothelial markers. We randomized 65 dysglycemic patients to placebo or the nutraceutical agent for 6 months. We evaluated fasting plasma glucose (FPG), postprandial plasma glucose (PPG), HbA Topics: Ascophyllum; Blood Glucose; C-Reactive Protein; Dietary Supplements; Double-Blind Method; Dyslipidemias; Female; Fucus; Humans; Male; Plant Extracts; Tumor Necrosis Factor-alpha	2019

Article

Year

Ascophyllum nodosum and Fucus vesiculosus on glycemic status and on endothelial damage markers in dysglicemic patients.

Phytotherapy research : PTR, 2019, Volume: 33, Issue:3

The aim of this study was to evaluate a nutraceutical combination containing polyphenols extracted from Ascophyllum nodosum and Fucus vesiculosus and chromium picolinate on glyemic status; secondary outcomes were considered the changes on endothelial markers. We randomized 65 dysglycemic patients to placebo or the nutraceutical agent for 6 months. We evaluated fasting plasma glucose (FPG), postprandial plasma glucose (PPG), HbA

Topics: Ascophyllum; Blood Glucose; C-Reactive Protein; Dietary Supplements; Double-Blind Method; Dyslipidemias; Female; Fucus; Humans; Male; Plant Extracts; Tumor Necrosis Factor-alpha

2019